GLP-1 And Addiction: Mechanism, Missteps, And What Comes Next By Jason Kirby, chief medical officer, Recovery Centers of America A growing body of evidence suggests glucagon-like peptide-1 receptor (GLP-1R) agonists may influence reward pathways and craving, raising important questions for addiction research and drug development
In this study, the metabolic substrate of CB, d-alanine (dAla), was first conjugated with a photosensitizer (TPApy), which exhibits aggregationinduced emission (AIE), to produce dAlaTPAPy
Reporting suspected adverse reactions helps the MHRA monitor the safety of medicines and substances used in the UK
doi: 10.1016/j.intimp.2009.09.003 48 LiuJHongXLinDLuoXZhuMMoH
ZM: Data curation, Writing original draft, Writing review & editing